VA

VR Adviser Portfolio holdings

AUM $1.33B
1-Year Est. Return 6.92%
This Quarter Est. Return
1 Year Est. Return
+6.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.18B
AUM Growth
-$282M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$102M
2
+$9.18M
3
+$9.02M
4
ORKA
Oruka Therapeutics
ORKA
+$8.85M
5
SRZN icon
Surrozen
SRZN
+$7.38M

Top Sells

1
+$24.9M
2
+$9.36M
3
+$7.35M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$6.76M
5
TERN icon
Terns Pharmaceuticals
TERN
+$5.97M

Sector Composition

1 Healthcare 99.34%
2 Financials 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZURA icon
26
Zura Bio
ZURA
$240M
$6.48M 0.55%
5,023,166
+3,000,000
ARTV
27
Artiva Biotherapeutics
ARTV
$132M
$4.83M 0.41%
1,609,569
TRVI icon
28
Trevi Therapeutics
TRVI
$1.28B
$3.87M 0.33%
615,506
-650,951
APLT icon
29
Applied Therapeutics
APLT
$197M
$2.72M 0.23%
5,567,709
-4,422,882
FDMT icon
30
4D Molecular Therapeutics
FDMT
$530M
$2.19M 0.19%
677,600
-2,274,771
CASI icon
31
CASI Pharmaceuticals
CASI
$25.4M
$2.13M 0.18%
987,259
TENX icon
32
Tenax Therapeutics
TENX
$33.7M
$1.36M 0.12%
208,333
MRSN icon
33
Mersana Therapeutics
MRSN
$48.8M
$1.23M 0.1%
142,973
-267,339
IPSC icon
34
Century Therapeutics
IPSC
$49.9M
$1.19M 0.1%
2,498,069
-1,459,117
TNYA icon
35
Tenaya Therapeutics
TNYA
$271M
$887K 0.08%
1,555,556
CBIO
36
Crescent Biopharma
CBIO
$213M
$630K 0.05%
30,000
TIL icon
37
Instil Bio
TIL
$131M
$576K 0.05%
33,177
TSHA icon
38
Taysha Gene Therapies
TSHA
$1.3B
– –
-3,225,180
AQST icon
39
Aquestive Therapeutics
AQST
$827M
– –
-2,629,786
MRUS icon
40
Merus
MRUS
$7.19B
– –
-592,411
TERN icon
41
Terns Pharmaceuticals
TERN
$680M
– –
-1,077,090
1
2